We are a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases. Bright Minds’ broad portfolio of new chemical entities (NCEs) are positioned to treat a variety of pain indications, seizures, and neuropsychiatric disorders.
/image%2F6304363%2F20210108%2Fob_186b9f_neuro.jpg)
Bright Minds a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases. Our team of neuroscientists, drug developers and physicians are tackling the big problems...
